CMS 2027 Final Rule: Less Friction, More Focus on the Consumer
During our recent National Call, we reviewed several key updates included in the CMS 2027 Final Rule and what they mean for agents moving forward.
The overall direction from CMS is clear: reduce unnecessary barriers while maintaining strong consumer protections. Rather than adding more administrative hurdles, CMS is shifting its focus toward transparency, consumer choice, and ensuring beneficiaries receive the information they need when they need it.
For agents, many of these changes create opportunities to serve clients more efficiently while continuing to operate within a compliant framework.
What’s Changing?
Scope of Appointment (SOA)
One of the most significant updates is the elimination of the 48-hour waiting period after completing a Scope of Appointment.
Under the new rule, once a valid SOA has been completed, agents may immediately discuss Medicare Advantage (Part C) and Prescription Drug Plans (Part D). This can occur during the same appointment, the same phone call, or on the same day the SOA is completed.
CMS recognizes that consumers often seek assistance when they are ready to make decisions. Removing the waiting period allows agents to respond more quickly while still obtaining the required authorization before discussing plan options.
Simplified Call Recording Requirements
CMS has also streamlined call recording requirements.
Moving forward, only calls that result in an enrollment must be recorded. In addition, marketing call retention requirements have been reduced to six years.
This change reduces administrative burdens while preserving accountability for enrollment-related conversations.
Clearer Third-Party Organization (TPO) Rules
Third-Party Organization disclaimers remain an important compliance requirement, but CMS has provided greater flexibility regarding when those disclosures must be delivered.
Rather than requiring the disclaimer at the beginning of every call, agents must ensure the disclosure is provided before discussing plan benefits. This adjustment allows conversations to flow more naturally while still ensuring consumers receive the necessary information before evaluating plan options.
More Flexible Educational and Marketing Events
Another welcome change is the elimination of the previous 12-hour separation requirement between educational events and sales or marketing events.
CMS is placing less emphasis on arbitrary time gaps and more emphasis on consumer understanding. The expectation remains that beneficiaries clearly understand when an educational discussion transitions into a sales presentation.
As agents, this means greater flexibility when planning educational workshops, seminars, and community outreach events while still maintaining clear communication and compliance standards.
Special Enrollment Period (SEP) Validation
Certain Special Enrollment Periods will now require validation directly through CMS.
In some cases, beneficiaries may need to complete enrollment through Medicare.gov or by contacting 1-800-MEDICARE. While CMS may control portions of the enrollment process, agents will continue to play a critical advisory role by helping beneficiaries understand eligibility requirements, evaluate plan options, and navigate available coverage choices.
What Hasn’t Changed?
While several requirements have become more flexible, many core compliance expectations remain firmly in place.
Agents must still:
- Obtain a valid Scope of Appointment before discussing Part C or Part D plans.
- Document how appointments were established.
- Avoid misleading, deceptive, or confusing marketing practices.
- Respect a consumer’s right to decline, pause, or end a conversation at any time.
For appointments generated through UIG programs, continue documenting the appointment source appropriately:
“Appointment set for Medicare Supplement review.”
Maintaining thorough documentation remains an important part of demonstrating compliance and protecting both agents and beneficiaries.
Additional Update: GLP-1 Bridge Demonstration Program
CMS has also announced a new GLP-1 Bridge Demonstration Program scheduled to begin July 1, 2026.
The program is intended to provide eligible Medicare beneficiaries with expanded access to certain GLP-1 medications. Additional guidance, eligibility requirements, and implementation details are expected from CMS as the launch date approaches.
We will continue monitoring developments and provide updates as more information becomes available.
Final Thoughts
For the first time in several years, many of these CMS updates represent a move toward greater flexibility rather than additional restrictions.
These changes allow agents to respond more quickly when consumers are ready, streamline administrative processes, and create a more natural client experience—all while preserving the safeguards beneficiaries deserve.
It’s important to remember that the expectation is not less compliance; it’s better compliance. Success under the new rules will still require clear communication, proper documentation, sound judgment, and a commitment to always putting the consumer first.
The agents who embrace these changes while maintaining a strong compliance mindset will be well-positioned for success during AEP and beyond. With fewer unnecessary obstacles standing in the way, we can spend more time focused on what matters most: educating clients, building trust, and helping beneficiaries make confident Medicare decisions.
As always, if you need more information on any of this, contact your DSM or Regional Sales Directors.
Mai-Lee Coddington
Regional Sales Director, SW